Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will describe the prescription conditions of botulinum toxin Type A (Botox®) injection for the treatment of urinary incontinence due to neurogenic detrusor overactivity (NDO) or idiopathic overactive bladder (IOAB) as per standard of care in clinical practice in France.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Botox® | Patients prescribed botulinum toxin Type A (Botox®) injection for the treatment of urinary incontinence associated with neurogenic detrusor overactivity or overactive bladder as per standard of care in clinical practice. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| botulinum toxin Type A | Biological | Botulinum toxin Type A (Botox®) injection as prescribed as standard of care in clinical practice. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Target Patients Prescribed Botox® in Clinical Practice | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Treatments Previously Prescribed | Day 1 | |
| Number of Sites Injected | Day 1 | |
| Total Dose of Botox® Used |
Not provided
Inclusion Criteria:
-Patients who receive a Botox® injection for urinary incontinence.
Exclusion Criteria:
-Patients not residing in France.
Not provided
Not provided
Not provided
Adult patients treated with Botox® for urinary incontinence associated with NDO or IOAB in clinical practice.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Medical Director | Allergan | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Site D'Aix En Provence | Aix-en-Provence | 13616 | France | |||
| CL Toulouse Lautrec |
Not provided
Not provided
Not provided
Not provided
| Day 1 |
| Types of Anaesthesia and Antibiotic Prophylaxis Used | Day 1 |
| Cytobacteriological Examination of the Urine | Day 1 |
| Total Number of Botox® Cycles in Non-naive Patients (previously received Botox®) | Day 1 |
| Length of Botox® Treatment in Non-naive Patients | Day 1 |
| Time Since Last Botox® Injection in Non-naive Patients | Day 1 |
| Characteristics of Injector Sites (Locations) | Day 1 |
| Characteristics of Injector Physicians | Day 1 |
| Characteristics of Patients | Day 1 |
| Number of Patients by Pathology History | Day 1 |
| Number of Patients by Medical and Surgical History | Day 1 |
| Reduction of Number of Daily Urinary Incontinence Episodes in Non-naive Patients | Day 1 |
| Percentage of Continent Patients in Non-naive Patients | Day 1 |
| Number of Adverse Events during the Visit | Day 1 |
| Albi |
| 81000 |
| France |
| CHU Angers | Angers | 49033 | France |
| CH Angouleme | Angoulême | 16959 | France |
| CH Avranches Granville | Avranches | 50300 | France |
| CH Bagnols Sur Ceze | Bagnols-sur-Cèze | 30200 | France |
| CH Belfort | Belfort | 90016 | France |
| CHU Besancon | Besançon | 25030 | France |
| CL Saint Augustin | Bordeaux | 33000 | France |
| CHU Bordeaux | Bordeaux | 33076 | France |
| CH de Cahors | Cahors | 46000 | France |
| CH Châlons-en-Champagne | Châlons-en-Champagne | 51000 | France |
| CHU Clermont Ferrand | Clermont-Ferrand | 63003 | France |
| CH Colmar | Colmar | 68024 | France |
| CHU Mondor (APHP) | Créteil | 94010 | France |
| CH Hopale Ctre Calot/Helio | Cucq | 62780 | France |
| CHU Dijon | Dijon | 21079 | France |
| CHI E.Durkheim Plateau de La Justice | Épinal | 88021 | France |
| CH Raymond Poincare (APHP) | Garches | 92380 | France |
| CH Renee Sabran Hyeres (HCL) | Giens-Hyeres | 83406 | France |
| GH de la Rochelle Ré-Aunis | La Rochelle | 17000 | France |
| CH Bicêtre (APHP) | Le Kremlin-Bicêtre | 94270 | France |
| CH Le Mans | Le Mans | 72037 | France |
| CHU Limoges | Limoges | 87042 | France |
| CL Mutualiste Porte de L'Orient | Lorient | 56100 | France |
| CH de la Conception (APHM) | Marseille | 13005 | France |
| CH Mont de Marsan | Mont-de-Marsan | 40000 | France |
| CL Beau Soleil | Montpellier | 34070 | France |
| CHU Montpellier | Montpellier | 34090 | France |
| CH Mulhouse | Mulhouse | 68100 | France |
| CHU Nimes | Nîmes | 30029 | France |
| GH Saint Joseph | Paris | 75014 | France |
| CH Tenon (APHP) | Paris | 75020 | France |
| CH Lyon Sud (HCL) | Pierre-Bénite | 69495 | France |
| CH de Pontoise | Pointoise Cedex | 95301 | France |
| USLD de Lusignan | Poitiers | 86021 | France |
| CH Annecy | Pringy | 74374 | France |
| SIH Privas La Voulte | Privas | 07007 | France |
| Polyclinique Les Bleuets | Reims | 51100 | France |
| CHU de Rennes | Rennes | 35033 | France |
| CHU de Rouen | Rouen | 76031 | France |
| CL de L'Alliance Saint Cyr/Loire | Saint Cyr/Loire | 37540 | France |
| CH Saint-Avold | Saint-Avold | 57500 | France |
| CL Mutualiste Chirurgicale | Saint-Etienne | 42100 | France |
| CH de Saintonge (Saintes) | Saintes | 17108 | France |
| Hôpital Civil / Nouvel Hôpital Civil | Strasbourg | 67000 | France |
| CH Foch | Suresnes | 92150 | France |
| Clinique de l'Ormeau Pyrénées | Tarbes | 65000 | France |
| CHU Toulouse | Toulouse | 31059 | France |
| CHU Tours | Tours | 37044 | France |
| ID | Term |
|---|---|
| D053201 | Urinary Bladder, Overactive |
| D001750 | Urinary Bladder, Neurogenic |
| ID | Term |
|---|---|
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019274 | Botulinum Toxins, Type A |
| ID | Term |
|---|---|
| D001905 | Botulinum Toxins |
| D008666 | Metalloendopeptidases |
| D010450 | Endopeptidases |
| D010447 | Peptide Hydrolases |
| D006867 | Hydrolases |
| D004798 | Enzymes |
| D045762 | Enzymes and Coenzymes |
| D045726 | Metalloproteases |
| D001426 | Bacterial Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D001427 | Bacterial Toxins |
| D014118 | Toxins, Biological |
| D001685 | Biological Factors |
Not provided
Not provided